AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000044 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
319,055
Total Value
$522,872.80
P&L
+inf% (+$6,184,920.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 151,603 | Direct | โ | View Details | |
Director | Common stock | โ | Mar 2, 2026 | Sale | 3,870 | $28.96 | $112,075.20 | 147,733 | Direct | โ | View Details | |
Director | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 18,000 | $0.00 | $0.00 | 165,733 | Direct | โ | View Details | |
Director | Common stock | โ | Mar 2, 2026 | Sale | 8,267 | $28.96 | $239,412.32 | 157,466 | Direct | โ | View Details | |
Director | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 13,000 | $0.00 | $0.00 | 170,466 | Direct | โ | View Details | |
Director | Common stock | โ | Mar 2, 2026 | Sale | 5,918 | $28.96 | $171,385.28 | 164,548 | Direct | โ | View Details | |
Director | Restricted stock units | Derivative | Mar 1, 2026 | Grant/Award | 48,000 | $0.00 | $0.00 | 48,000 | Direct | โ | View Details | |
Director | Stock options (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 174,000 | $0.00 | $0.00 | 174,000 | Direct | โ | View Details | |
Director | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 18,000 | $0.00 | $0.00 | 18,000 | Direct | โ | View Details | |
Director | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 13,000 | $0.00 | $0.00 | 26,000 | Direct | โ | View Details |